10 may 2020

#STOPconfinamiento Trump revela al MUNDO LA CURA-DIOXIDO DE CLORO del COVID que no UTILIZARA nunca BILL GATES, OMS y el NOM




Hay que admitir que Trump esta dando pasos muy interesantes en la confrontacion de la cabal satanica y su programa eugenistico de reducción de la población a base de pandemias y vacunas oblitarias,su ultima y sorprende revelación fue reconocer como cura el MMS, CDS  DIOXIDO DE CLORO, los medios de desinformación masivos,le han atacado sin ningun tipo de rigor y desinformando,como nos tienen acostumbrados los medios del regimen genocida  a sueldo de sanchez y sus 15 millones de subvención,como la sexta ye l gorila trepa,diciendo que se tomaban lejia, también se apuntaron al carro todos los promulgadores de bulos de los medios oficiales ana rosa quinta etc..etc...

Aqui estan los estudios medicos que lo avalarían REPITO NO ES LEJIA es un producto que se HA USADO SIEMPRE EN MEDICINA, y no provoca ningun efecto secundario, el que diga que es legio o es un necio borrego o es un peligroso desinformador a sueldo de la farmafia o la industria de las vacunas y el plan de eugenesia a nivel mundial.


El presidente de Estados Unidos ha vuelto a sorprender con sus soluciones para acabar con el coronavirus. Este jueves ha propuesto un nuevo y revolucionario método para superar la pandemia. Durante su rueda de prensa diaria en la Casa Blanca, Trump ha propuesto inyectar “desinfectante” a los enfermos para poder “limpiar los pulmones”. Trump cree que es “interesante” probar la idea ya que ha quedado demostrado que un desinfectante mata al virus en un minuto.


https://www.mallorcadiario.com/trump-desinfectante-remedio-coronavirus

ESTO ES EL CDS O CLORURO DE SODIO NI ES LEJEIA NI MATA Y SE LLEVA USANDO AÑOS EN LA MEDICINA GENERAL CURA EL VIRUS EN MINUTOS


es un ANTI VIRAL NO ES LEJIA

Hay que entender que el principal objetivo del COVID es implantar las VACUNAS OBLIGATORIA ya desarrolladas desde hace timepo al mismo ttiempo que se creo el virus como nostos dijimos para septiembre tendran ya preparadas esas vacunas altamente venenossas, aqui los datos;


Efecto protector del gas de dióxido de cloro de baja concentración contra la infección por el virus de la influenza A.


La infección por el virus de la influenza es una de las principales causas de morbilidad y mortalidad humanas. Entre los humanos, este virus se propaga principalmente a través de aerosoles excretados del sistema respiratorio. Los medios actuales de prevención de la infección por el virus de la influenza no son completamente satisfactorios debido a su eficacia limitada. Se necesitan medidas preventivas seguras y efectivas contra la influenza pandémica. Demostramos que la infección de ratones inducida por aerosoles del virus de la influenza A se evitó con gas dióxido de cloro (ClO (2)) a una concentración extremadamente baja (por debajo del nivel de exposición permisible a largo plazo a los humanos, es decir, 0,1 ppm). Los ratones en jaulas semicerradas fueron expuestos a aerosoles del virus de la influenza A (1 LD (50)) y gas ClO (2) (0,03 ppm) simultáneamente durante 15 minutos. Tres días después de la exposición, el título del virus pulmonar (TCID (50)) fue 10 (2.6 +/- 1.5) en cinco ratones tratados con ClO (2), mientras que fue 10 (6.7 +/- 0.2) en cinco ratones que no habían recibido sido tratado (P = 0.003). La mortalidad acumulada después de 16 días fue de 0/10 ratones tratados con ClO (2) y 7/10 ratones que no habían sido tratados (P = 0,002). En experimentos in vitro, ClO (2) desnaturalizó las proteínas de la envoltura viral (hemaglutinina y neuraminidasa) que son indispensables para la infectividad del virus y abolió la infectividad. Tomados en conjunto, concluimos que el gas ClO (2) es efectivo para prevenir la infección por virus de la influenza inducida por aerosol en ratones al desnaturalizar las proteínas de la envoltura viral a una concentración muy por debajo del nivel de exposición permisible para los humanos. Por lo tanto, el gas ClO (2) podría ser útil como un medio preventivo contra la influenza en lugares de actividad humana sin necesidad de evacuación.

Este enlace fue borrado a las horas de publicarlo
https://pubmed.ncbi.nlm.nih.gov/18089729/https://docs.google.com/document/d/1545C_dJWMIAgqeLEsfo2U8Kq5WprDuARXrJl6N1aDjY/preview?pru=AAABcewg1u0*30h8EHA8W-jicDkHQDdSpw


Recuperado aqui;
https://www.ncbi.nlm.nih.gov/pubmed/18089729


LA CURA PROHIBIDA PASALO¡¡¡.mp4
https://videos.utahgunexchange.com/watch/la-cura-prohibida-pasalo-mp4_GcukJWeGkoYGJz3.html





Sequential CQ / HCQ Research Papers and Reports
January to April 20, 2020
Executive Summary Interpretation of the Data In This Report
The HCQ-AZ combination, when started immediately after diagnosis, appears to be a safe and efficient treatment for COVID-19, with a mortality rate of 0.5%, in elderly patients. It avoids worsening and clears virus persistence and contagious infectivity in most cases.












Sequential CQ / HCQ Research Papers and Reports
                                January to April 12, 2020


22 August 2005
CDC Special Pathogens Branch 
MJ VIncet, E.Bergon, S. Benjannet, BR Erickson, Pierre Rollin, T.G. Ksiazek, NG Seidah, 
ST Nichole. Chloroquine is a potent inhibitor of SARS coronavirus infection and spread. Virology Journal. (2005) 2: 69
Chloroquine has strong antiviral effects on SARS CoV infection of primate cells in tissue culture. These inhibitory effects are observed when cells are treated with the drug either before or after exposure to the virus, suggesting both prophylactic preventative and treatment use. The paper describes three mechanisms by which the drug might work and suggest it may have both a prophylactic and therapeutic role in Coronavirus infections.


                                    ……………………………………………………………………………………….
28 January 2020
M. Wang, R. Cao, L. Zhang, X. Yang, J. Liu, M. Xu, Z. Shi, Z. Hu, W. Zhong, G. Xiao
LETTER TO THE EDITOR  Cell Research Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro. Cell Research (2020) 0:1–3; https://doi.org/10.1038/s41422-020-0282-0
Tested Remdesivir and Chloroquine in addition to five other drugs were tested in tissue culture against a clinical sample of virus from a COVID-19 patient,  Remdesivir and Chloroquine are highly effective in the control of 2019-nCoV infection in vitro. Since these compounds have been used in human patients with a safety track record and shown to be effective against various ailments, we suggest that they should be assessed in human patients suffering from the novel coronavirus disease.


February 13, 2020  
Physicians work out treatment guidelines for coronavirus, Korea Biomedical Review    http://www.koreabiomed.com/news/articleView.html?idxno=7428
The Korean  COVID-19 Central Clinical Task Force, held the sixth video conference and agreed on treatment principles for patients with COVID-19.


  • Young with mild symptoms without underlying conditions, doctors can observe them without antiviral treatment.


  • If 10 days have passed since the onset of the illness and the symptoms are mild, physicians do not have to start an antiviral medication.
  • If patients are old or have underlying conditions with serious symptoms, physicians should consider an antiviral treatment as soon as possible. lopinavir 400mg/ritonavir 100mg (Kaletra two tablets, twice a day) or chloroquine 500mg orally per day. Alternate is hydroxychloroquine 400mg orally per day.
February 18, 2020.
Jianjun Gao, Zhenxue Tian, Xu Yang  Breakthrough: Chloroquine phosphate has shown apparent efficacy in treatment of COVID-19 associated pneumonia in clinical studies. BioScience Trends Advance Publication, DOI: 10.5582/bst.2020.0104
Thus far, results from more than 100 patients have demonstrated that chloroquine phosphate is superior to the control treatment in inhibiting the exacerbation of pneumonia, improving lung imaging findings, promoting a virus negative conversion, and shortening the disease course. 
Severe adverse reactions to chloroquine phosphate were not noted in the aforementioned patients. Given these findings, a conference was held on February 15, 2020; participants including experts from government and regulatory authorities and organizers of clinical trials reached an agreement that chloroquine phosphate has potent activity against COVID-19.


27 February 2020
Philippe Colson , Jean-Marc Rolain , Jean-Christophe Lagier , Philippe Brouqui , Didier Raoult , Chloroquine and hydroxychloroquine as available weapons to fight COVID-19, International Journal of Antimicrobial Agents  Feb (2020), doi: https://doi.org/10.1016/j.ijantimicag.
2020.105932
following the very recent publication of results showing the in vitro activity of chloroquine against SARS-CoV-2, data have been reported on the efficacy of this drug in patients with SARS-CoV-2-related pneumonia (named COVID-19) at different levels of severity. 
Following the in vitro results, 20 clinical studies were launched in several Chinese hospitals. 
The first results obtained from more than 100 patients showed the superiority of chloroquine compared with treatment of the control group in terms of reduction of exacerbation of pneumonia, duration of symptoms and delay of viral clearance, all in the absence of severe side effects. This has led in China to include chloroquine in the recommendations regarding the prevention and treatment of COVID-19 pneumonia. 
Chinese teams showed that Chloroquine could reduce the length of hospital stay and improve the evolution of COVID-19 pneumonia, leading to recommend the administration of 500 mg of chloroquine twice a day in patients with mild, moderate and severe forms of COVID-19 pneumonia. 


4 March 2929
Philippe Colson,a,b Jean-Marc Rolain,a,b Jean-Christophe Lagier,a,b Philippe Brouqui,a,b and Didier Raoult, Chloroquine and hydroxychloroquine as available weapons to fight COVID-19. Int J Antimicrob Agents. 2020 Mar 4 : 105932. doi: 10.1016/j.ijantimicag.2020.105932 [Epub ahead of print]  PMCID: PMC7135139   IPMID: 32145363
A review of the safety and efficiency of CQ and HCQ reviewing more than 20 clinical studies in several Chinese hospitals. 
Although only available in letter form, this data caused China to  recommend Chloroquine in the National Guidelines for the Treatment of COVID-19.


9 March 2020
X.Yao, F/ Ye2, M. Zhang, C.Cui, R. Lu, H. Li, W. Tan, D. Liu. In Vitro Antiviral Activity and Projection of Optimized Dosing Design of Hydroxychloroquine for the Treatment of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2). 2020.. Clin Infect Dis. 2020 Mar 9. pii: ciaa237. doi: 10.1093/cid/ciaa237.
Hydroxychloroquine was found to be more potent than chloroquine at inhibiting SARS-CoV-2 in vitro. Hydroxychloroquine sulfate 400 mg given twice daily for 1 day, followed by 200 mg twice daily for 4 more days is recommended to treat SARS-CoV-2 infection.


9 March 2020
Expert Chinese consensus on Chloroquine Phosphate for New Coronavirus Pneumonia. Diagnosis and Treatment Plan. Chinese Journal of Tuberculosis and Respiratory Diseases. 2020, 43:
A Multicenter Collaboration Group was formed to guide and standardize the use of Chloroquine in Coronavirus pneumonia, standardizing Chloroquine treatment at 500mg 2x day for 10 days. Use of azithromycin was contraindicated.


20 March 2020
Gautret PLagier JCParola PHoang VTMeddeb LMailhe MDoudier B, Giordanengo V, Vieira VELa Scola BRolain JMBrouqui PRaoult D. Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial. Int J Antimicrob Agents. 2020 Mar 20:105949. doi: 10.1016/j.ijantimicag.2020.105949. 
Confirmed COVID-19 patients were included in a protocol from early March to March 16th, to receive  600mg of hydroxychloroquine daily and their viral load in nasopharyngeal swabs was tested daily in a hospital setting. 
Untreated patients from another center were included as negative controls. 
20 cases were treated in this study and showed a significant reduction of the viral levels at D6-post inclusion compared to controls, and much lower average carrying duration than reported of untreated patients in the literature. Azithromycin added to hydroxychloroquine was significantly more efficient for virus elimination.
Despite its small sample size our survey shows that hydroxychloroquine treatment is 
significantly associated with viral load reduction/disappearance in COVID-19 patients and its effect is reinforced by azithromycin,


20 March 2020
Mount Sinai health system treatment guidelines for SARS-CoV-2 infection (COVID-19) https://www.mountsinai.org/health-library/diseases-conditions/2019-novel-coronavirus-2019-ncov Last accessed on 20th March 2020.
Mount Sinai Heath System establishes protocols for dosing and treatment of COVID-19 patients using Chloroquine and Hydroxychloroquine.




27 March 2020
P. Gautret, J.C. Lagier, P. Parola, V.T. Hoang, T. Dupont, S. Honoré, A. Stein, M. Million, B. La Scola, P. Brouqui, Didier Raoul. Hydroxychloroquine-Azithromycin Treatment for COVID-19 Shown to be Effective in an 80-Patient Study
IHU-Méditerranée Infection, Marseille, France  March 27, 2020 
In 80 patients receiving hydroxychloroquine and azithromycin we noted a clinical improvement in all but one 86 year-old patient who died, and one 74 year still in ICU. A rapid fall of nasopharyngeal viral load tested by qPCR was noted, with Virus cultures from patient respiratory samples turning negative in 97.5% patients at Day 5. 
This allowed patients to rapidly be discharged from highly contagious wards with a mean length of stay of five days.


10 March 2020
Cortegiani A., Ingoglia G., Ippolito M., Giarratano A., Einav S. A systematic review on the efficacy and safety of chloroquine for the treatment of COVID-19. J Crit Care. 2020 Mar 10;(20):30390–30397.
A review was made of six articles (one narrative letter, one in-vitro study, one editorial, expert consensus paper, two national guideline documents) and these clinical trials done in China. 


ChiCTR2000030417 COVID-19 pneumonia                       (n = 30)                 Chloroquine phosphate
ChiCTR2000030054     COVID-19 pneumonia                       (n = 100)                  HCQ  0.2 g BID × 14 days
ChiCTR2000030031 COVID-19 pneumonia                       (n = 120)               400 CQ BID   2 tablets placebo BID
ChiCTR2000029992 Severe COVID pneumonia                (n = 100)                 CQ 1.0 g × 2 days, then 0.5 g × 12 day                                                                                                                                          
                                                                                                                                        HCQ 0.2 g BID x 14 days
ChiCTR2000029988    Severe COVID-19 pneumonia            (n = 80)                 CQ Standard Rx -Clinical Recovery
ChiCTR2000029975    COVID-19 pneumonia                         (n = 10)                 CQ inhalation aerosol 
ChiCTR2000029939    COVID-19 pneumonia                         (n = 100)                  CQ Standard treatment
ChiCTR2000029935 Single-arm clinical trial                       (n = 100)                 CQ No comparison 
ChiCTR2000029899 Mild COVID-19 pneumonia                (n = 100)                 HCQ:  6 tablets (0.2 g/ 6 tablets/day 
ChiCTR2000029898 Severe COVID pneumonia                  (n = 100)                 HCQ Hydroxychloroquine 2 tablets/day 
ChiCTR2000029868 COVID-19 pneumonia                         (n = 200)                 HCQ Standard Rx Viral test
ChiCTR2000029837 Mild COVID-19 pneumonia                (n = 120)                 HCQ tablets and placebo BID
ChiCTR2000029826 Critically ill COVID-19 pneumonia     (n = 45)                   2 tablets CQ BID- placebo BID
ChiCTR2000029803 Close contacts with confirmed          (n = 320)                 HCQ- high dose 
ChiCTR2000029762 COVID-19 pneumonia                          (n = 60)                   HCQ Standard treatment
ChiCTR2000029761 COVID-19 pneumonia                          (n = 240)                 HCQ Medium-dose group: 
ChiCTR2000029741 Mild COVID-19 pneumonia                 (n = 112)                 CQ oxygen index during treatment; 
ChiCTR2000029740 COVID-19 pneumonia                           (n = 78)                   HCQ 0.2 g BID Lab testing
ChiCTR2000029609 Non-randomized controlled trial        (n = 205)                 Mild-moderate CQ group:  CQ plus Lopinavir/ritonavir; Severe CQ                 
                                                                                                                                           group; Severe Lopinavir/Ritonavir group: 
ChiCTR2000029559 COVID-19 pneumonia                           (n = 300)                 Group 1: Hydroxychloroquine 0.1 g oral BID; Group 2: 
                                                                                                                                           Hydroxychloroquine 0.2 g oral BID   Placebo control group: Starch
ChiCTR2000029542 COVID-19 pneumonia                            (n = 20) Oral chloroquine 0.5 g BID for 10 days 30-day specific mortality
NCT04286503 Critically ill COVID-19                            (n = 520) Carrimycin, lopinavir/ritonavir or Arbidol or CQ

  • Chloroquine seems to be effective in limiting the replication of SARS-CoV-2 in vitro.

  • There is rationale, evidence of effectiveness and evidence of safety from long-time clinical use for other indications to justify clinical research on chloroquine in patients with COVID-19. 

  • Safety data and data from high-quality clinical trials are urgently needed.


21 March 2020
Duan YJLiu QZhao SQHuang FRen LLiu LZhou YW. The Trial of Chloroquine in the Treatment of COVID-19 and Its Research Progress in Forensic Toxicology. 2020 Mar 25;36(2). doi: 10.12116/j.issn.1004-5619.2020.02.001. [Epub ahead of print]
Chloroquine is a long-established prescription drug that is often used clinically to treat malaria and connective tissue diseases. The antimalarial drug Chloroquine phosphate which has already been approved is confirmed to have an anti-SARS-CoV-2 effect and has been included in diagnostic and therapeutic guidelines. However, awareness of the risk of chloroquine phosphate causing acute poisoning or even death should be strengthened. The dosage used according to current clinical recommended dosage and course of treatment are larger than that of previous treatment of malaria. Many provinces have required close clinical monitoring of adverse reactions. This paper reviews the pharmacological effects, poisoning and toxicological mechanisms, in vivo metabolism and distribution, and forensic issues of chloroquine drugs, in order to provide help to forensic practice and clinical work


21 March 2020
Chloroquine US prescribing information. https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/009768s037s045s047lbl.pdf (Last accessed March 21, 2020)


23 March 2020
Yueping Li, Zhiwei Xie, Weiyin Lin, Weiping Cai, et.al, An exploratory randomized, controlled study on the efficacy and safety of lopinavir/ritonavir or arbidol treating adult patients hospitalized with mild/moderate COVID-19 
doi: https://doi.org/10.1101/2020.03.19.20038984
According to investigators, adding hydroxychloroquine (HCQ), on top of conventional therapy didn’t shorten the time to SARS-CoV-2 clearance in a 30-patient trial. No significant differences were observed across the two arms in terms of the time it took to bring body temperature to normal or the number of patients with disease progression as shown in CT scans.
However, a careful examination of the study reveals a more complicated situation. Most patients in the study's control group were actually treated with other antiviral drugs at the same time, including the HIV combo med Kaletra and the Russian flu drug Arbidol. Most, but not all, patients in the hydroxychloroquine group were also treated with Arbidol. All patients also received interferon-alpha, thereby completely invalidating any assessment of Chloroquine effects.


24 March 2020
Pagliano PPiazza ODe Caro FAscione TFilippelli A. Is Hydroxychloroquine a possible post-exposure prophylaxis drug to limit the transmission to health care workers exposed to COVID19? Clin Infect Dis. 2020 Mar 24. https://www.ncbi.nlm.nih.gov/pubmed/32211764
PMID: 32211764    DOI: 10.1093/cid/ciaa320 
Chloroquine and Hydroxychloroquine are able to inhibit replication at early stages of viral
infection. No similar effect on early phases of Coronavirus infection has been reported for other drugs proposed for SARS-CoV-2 treatment, which are able to interfere only after cell infection.
We believe that hydroxychloroquine can be effective in preventing respiratory tract invasion in HCW and that hydroxychloroquine administration as prophylactic agent could be particularly useful for HCW attending to high risk procedures on respiratory tract in COVID-19 patients. 


Hydroxychloroquine effectiveness profile, its ability to inhibit lung viral replication for a 10-day period after only a 5- day cycle of therapy, and the large amounts of knowledge in term of safety deriving from its use for malaria prophylaxis and rheumatologic diseases permit to recommend its pre-exposure or post-exposure use for those performing procedures at high risk of viral diffusion in patients with COVID-19 pneumonia. 


26 March 2020
A.K. Singh,, A. SinghA. ShaikhR. Singh, and A. Misra. Chloroquine and hydroxychloroquine in the treatment of COVID-19 with or without diabetes: A systematic search and a narrative review with a special reference to India and other developing countriesDiabetes Metab Syndr. Published online 2020 Mar26. doi: 10.1016/j.dsx.2020.03.011
PMCID: PMC7102587   PMID: 32247211
A systematic review of Hydroxychloroquine and COVID-19


7 April 2020
Belgium Task Force Interim clinical guidelines for patients suspected of / confirmed with COVID-19 infection. 


Based on pharmacokinetic simulations, the recommended dosing of hydroxychloroquine sulphate is 400mg BID on day 1, followed by 200mg BID on day 2-5. 
Because of the long elimination half-life of the drug (32–50 days), the duration of treatment should not exceed 5 days to avoid accumulation of hydroxychloroquine concentrations in plasma and tissues, and associated increased risk of toxicity, and because there is no in vitro evidence that longer courses improve drug activity on SARS-CoV-2.


10 April 2020Zhaowei Chen, VJijia Hu, Zongwei Zhang, Shan Jiang, Shoumeng Han, Dandan Yan, Ruhong Zhuang, Ben Hu, Zhan Zhang Efficacy of hydroxychloroquine in patients with COVID-19: results of a randomized clinical trial doi:https://doi.org/10.1101/2020.03.22.20040758 
Evidence regarding the in-vivo use of Hydroxychloroquine is limited. In COVID-19 infection. This study evaluated the efficacy of hydroxychloroquine (HCQ) in the treatment of patients with COVID-19. From February 4 to February 28, 2020, 62 patients suffering from COVID-19 were diagnosed and admitted to Renmin Hospital of Wuhan University. All participants were randomized in a parallel-group trial, 31 patients were assigned to receive an additional 5-day HCQ (400 mg/d) treatment, Time to clinical recovery (TTCR), clinical characteristics, and radiological results were assessed at baseline and 5 days after treatment to evaluate the effect of HCQ. 


For the 62 COVID-19 patients, 46.8% (29 of 62) were male and 53.2% (33 of 62) were female, the mean age was 44.7 (15.3) years. No difference in the age and sex distribution between the control group and the HCQ group. But for TTCR, the body temperature recovery time and the cough remission time were significantly shortened in the HCQ treatment group. Besides, a larger proportion of patients with improved pneumonia in the HCQ treatment group (80.6%, 25 of 31) compared with the control group (54.8%, 17 of 31). Notably, all 4 patients progressed to severe illness that occurred in the control group. However, there were 2 patients with mild adverse reactions in the HCQ treatment group. Significance: Among patients with COVID-19, the use of HCQ could significantly shorten TTCR and promote the absorption of pneumonia.
Clinical Trial   ChiCTR2000029559


10 April 2020
This data is supportive of preliminary evidence suggesting a significant reduction in the average length of hospital stay (ALOS)  in COVID-19 patients administered hydroxychloroquine (HCQ) alone.


This crude data was generated by a multi-center data collection effort conducted by Agilum Healthcare Intelligence Inc. based in Brentwood, Tennessee and analyzed with respect to the COVID length of hospital stay under various investigational treatments.



The unpublished data was generated from a bell-curve of patient severities encompassing all levels of severity. Hence, it only provides a gross estimation of a Hydroxychloroquine effect in COVID-19 patients. However it is supportive of the French Data released on 12 April 2020 as an Abstract.


12 April 2020
Raoult, D. Cohort of 1061 COVID-18 cases treated with HCQ-AZ Combination with 9 day follow-up. IHU Méditerranée Infection, Marseille. http://covexit.com/professor-didier-raoult-releases-the-results-of-a-new-hydroxychloroquine-treatment-study-on-1061-patients/
A cohort of 1061 COVID-19 patients, treated for at least 3 days with the HCQ-AZ combination and a follow-up of at least 9 days was investigated. Endpoints were death, worsening and viral shedding persistence. From March 3rd to April 9th, 2020, 59,655 specimens from 38,617 patients were tested for COVID-19 by PCR. Of the 3,165 positive patients placed in the care of our institute, 1061 previously unpublished patients met the inclusion criteria for a Hydroxychloroquine –Azithromycin trial.
Mean age was 43.6 years old and 492 were male (46.4%), As in other studies, no cardiac toxicity was observed in this study. 


  • A good clinical outcome and virological cure was obtained in 973 patients out of a total pf 1061 patients within 10 days (91.7%). 


  • Mortality was significantly lower in patients who had received > 3 days of HCQ-AZ than in patients treated with other regimens both at IHU and in all Marseille public hospitals (p< 10-2).


A poor outcome was observed for 46 patients (4.3%); -10 were transferred to intensive care units, 5 patients died (0.47%) (74-95 years old), 31 required 10 days of hospitalization or more. 
Among this group, 25 patients are now cured and 16 are still hospitalized (98% of patients cured so far). 


Table 1. Baseline characteristics according to clinical and virological outcome of 1061 patients treated with HCQ + AZ ≥ 3 days at IHU Méditerranée infection Marseille, France with Day 0 between March 3 and March 31, 2020 
C:\Users\GMZiegler\Work Folders\Desktop\Picture1.png
Prolonged viral carriage at completion of treatment was observed in 47 patients (4.4%) and was associated with a higher viral load and more advanced disease at diagnosis (p < 10-2) but viral culture was negative at day 10 and all but one were PCR-cleared at day 15. 


Poor clinical outcome was significantly associated to older age (OR 1.11), initial higher severity (OR 10.05) and low Hydroxychloroquine serum concentration. 


In addition, both poor clinical and virological outcomes were associated with patients taking selective beta-blocking agents and angiotensin II receptor blockers (P<0.05) for Hypertension.


13 April 2020
J. Gao, Hu, S., Update on use of Hydroxychloroquine to TREAT coronavirus disease 2019 (COVID-19). 
Increasing evidence from completed clinical studies indicates the prospects for the treatment of COVID-19 by Chloroquine and Hydroxychloroquine (indications Hydroxychloroquine is more effective).
  • Chloroquine has indicated its efficacy in mild and moderate COVID-19 cases. 
  • Chloroquine is superior to Lopinavir/ritonavir in improving COVID-19 lung lesions.
  • Chloroquine has demonstrated significant efficacy in returning body temperature to normal.
  • Hydroxychloroquine seems more effective than Chloroquine in a French study on reducing the amount of virus in the body.
  • Hydroxychloroquine helps reduce the duration of cough, reduce the amount of virus in the body and improve negative lung lesions on X-ray.
  • We have already commented on the single paper involving 15 patients subjected simultaneously to Interferon-Alpha, arbidol, and lopinavir/ritonavir in the control group.
In general, completed clinical studies have yielded promising results regarding the safety and effectiveness of Chloroquine and Hydroxychloroquine in the TREATMENT of COVID-19


Summary of Bibliography Review
Dependent upon a successful peer review of the data presented in 1,061 COVID-19 patients, treated for at least 3 days with the HCQ-AZ combination in the French Abstract released 12 April 2020, by D. Raoult of the IHU Méditerranée Infection and a successful review of the 10 April 2020 paper by Zhaowei Chen et.al, ……
………….the use of HCQ-AZ combination when started immediately after diagnosis, appears to be a safe an efficient treatment for COVID-19. It appears to halt respiratory disease progression and length of hospital stay in many cases.
Within the context of an expanding COVID-19 pandemic, it is reasonable to propose the EARLY use of Hydroxychloroquine in attempt to reduce the number of COVID patient hospitalization days, and hence provide an increased rate of patient turnover and a more efficient use of limited hospital ventilators. 
The finding in the gross data study done on 10 April 2020 showing a slightly prolonged Average Length of Hospital Stay (ALOS) in the population group given HCQ/CQ/Azithromycin, requires further investigation. Azithromycin can show the same cardiac conduction effects as Chloroquine in humans, but there has not been a widespread aversion to its being prescribed. Some 4,000 individuals have now been given what are considered to be COVID doses of Hydroxychloroquine, and not one cardiac conduction problem has been noted. 
Opinion
Historical controls are used in many previous studies in medicine. In this respect, the safety of Hydroxychloroquine is well documented. When the safe use of this drug is projected against its apparent effect of decreasing the progression of early cases to ventilator use, it is difficult to understand the reluctance of the authorities in charge of U.S. pandemic management to recommend its use in early COVID-19 cases. The effects of the chloroquines were first outlined 15 years ago by the CDC’s own Special Pathogens Unit. 


































No hay comentarios:

Related Posts Plugin for WordPress, Blogger...

world tv

PAGINA DE HORDASHISPANICAS R/EVOLUCION

Contrainformacion e investigacion,comprueba todos los enlaces y nunca des nada por sentado,RNWO:

AGENDA NWO-ILLUMINATI Y LA III GUERRA MUNDIAL


Image and video hosting by TinyPic


ZAPATERO MASON- ILLUMINATI GRADO 33:





“El jefe del Ejecutivo, José Luis Rodríguez Zapatero, pertenece a la Masonería.Mason grado 33. Así lo asegura el historiador Ricardo de La Cierva, que ha dedicado numerosos estudios a esta sociedad secreta. "

Saludos y diferentes poses ante los medios,en este caso con el tipico apreton de manos entre masones, desvelando tambien al influencia sobre el mismo Vaticano, les deletan como otro miembro de las sociedades secretas, como lo es tambien el ex-presidente Jose maria aznarMason grado 33 en la sociedad SKULL & BONES:Mas info aqui.







Manfestacion ante el club bilderberg un ejemplo de compromiso y activismo pacifico, todo un ejemplo que nos tiene que servir de inspiracion, mas info AQUI


DESPIERTA Y AYUDA A DESPERTAR
RNWO

Image and video hosting by TinyPicImage and video hosting by TinyPicImage and video hosting by TinyPic

La Unión Europea aprobó el día 5 de noviembre que las autoridades administrativas de los Estados miembros puedan cortar el acceso a Internet sin orden judicial previa


Continua AQUI


11M Operacion de falsa bandera al descubierto:OTAN-CMX

La denuncia de Mario Gascon[Confidente del 11-m y detenido en honduras acusado de espionaje "chacales del CNI Español]

Mario Gascon quien trabajo y a la vista de las ultimas informaciones continuaba haciendolo para el gobierno del sicario de los NWO zapatero,pues bien hizo la siguiente deunicia no solo publica en un medio de difusion tambien la presento ante la audinecia nacional y adivinen cual fue la respuesta de esta, carpetazo al mas piro estilo FASIAN:

Ha declarado que:

"El Chino le confesó que el 11-M se organizó con ayuda del CNI y los vascos". Esto mismo lo denunció por escrito en la Audiencia Nacional, pero nadie le hizo caso y se volvió a marchar fuera de España.

CONTINUA AQUI


LEY DEL SILECIO 11M: El obstruccionismo de Interior dilata el proceso contra Sánchez Manzano:

En los últimos días hemos sabido que el Ministerio del Interior ha denegado a las víctimas del 11M el protocolo de actuación de los TEDAX, petición que se enmarca en la fase de instrucción de la querella interpuesta por la Asociación de Ayuda a las Víctimas del 11M contra el que fuera comisario jefe de la Unidad Central de Tedax y NBQ, Juan Jesús Sánchez Manzano, y contra la jefa de laboratorio de dicha unidad



CANALES CENSURADOS EN YOUTUBE:

Otro canal censurado, en este caso las connotaciones claramente politicas, se trata del canal del youtube caballero ZP Tele 5 al parecer ha influido decididamente en la decision, ya que, este canal se caracterizaba con ser muy critico con los tiranos que nos gobiernas, inclinaciones politicas a un lado, yo personalmente no creo en ninguna, este tipo de censuras a dedo en un supuesto canal libre como el YOUTUBE,LA cesura en YOURUBE es una constante, desde que millones de personas han despertado y publican videos incomodos sobre los verdaderos planes de los Illuminati y su NWO, Desde aqui nos solidarizamos con todos los canales y videos censrados, seguiremos resistiendo para que los videos por la verdad y libertad continuen en sus redes.CENSURA S/ZIONISTAS $$NWO$$ EN YOUTUBE, CAZACHAMUCOS 2006katecon TRUTHEXPOSED001,


Hacer canales de refuerzo, subir los videos en varios canales asi sera muy dificil que perdais la informacion, pensar que se toman tantas molestias en censuraros porque vuestra informaicon molesta incomada al sistema NWO, NO PERMTAIS QUE OS SILENCIEN LIBERTAD Y RNWO.



TeleCIRCO censura , la cadena de TV, telecinco emite programas como GH, gran hermano, programacion illuminati,programacion de bajo nivel de contenidos puro entretenimiento para masas, programaicon rozando la ilegalidad en algunos casos, cumpliendo los obejtivos de la mafia illumianti para someter a la poblacion a la tirania de la friboldad y la programacion vacia de contenidos, videos incomodos, periodistas y medios de comunicacion "marionestas" Illuminati.

video por apologia al terrorismo en TELECIRCO.Ver video integro aqui.

VIDEO INCOMODO SOBRE LA DEMOLICION DE LAS TORRES GEMELAS Ver video: aqui

6 Videos CENSURADOS DE GOLPE/Daniel Estulin en la Noria,todos los videos en vimeo para ver los videos pinchar enlace.


Image and video hosting by TinyPicImage and video hosting by TinyPicImage and video hosting by TinyPicImage  and video hosting by TinyPic
11M/$ autoatentados consentidos por politicos y medios de comuniacion:

Evidencias cientificas de la demolicion de las torres

No nos merecemos un gobierno que nos mienta.
NOS ENGAÑARON A TODOS.
Operacino de bandera falsa OTAN CMX 11-M


Image and video hosting by TinyPic
Image and video hosting by TinyPicImage and video hosting by TinyPicImage and video hosting by TinyPic


Image and video hosting by TinyPicEXTREMADAMENTE GRAVE:Image and video hosting by TinyPic

Gobiernos y organismo internacionales implicados en una trama de controlar la poblacion mundial,

Mas informacion AQUI:

GRIPE A. La Vacuna: Crimen sin resolver


Baxter y su agenda genocida DENUNCIA EL GENOCIDIO!!!!!Image and video hosting by TinyPic
Dr. Moshes, detenido en una espectacular persecución por denunciar hace meses una trama vírica en Ucrania”
supresión de esta información por parte de los medios de comunicación de masas.
Image and video hosting by TinyPic

Leer mas aqui

HAARP ARMA ILLUMINATI EN CHILEy HAITI:Image and video hosting by TinyPic


Un autentico genocidio de proporciones atroces, lo hicieron en Haiti mas de 200.000 vidas humanas, y repitoeron en Chile, patrones repetdos estudios cientificos avalan el uso del arma HAARP, patente de EU y denunciada en la comision europea.



por hordashispanicas



La única forma de generar patrones sucesivos de profundidad idéntica, en réplicas discontinuas seguidas, es proyectando desde un satélite frecuencias de superficie, concentradas en un punto. No hay otra manera de conseguir ese efecto, ya que, los seísmos endógenos, obedecen a las propiedades de elasticidad de las placas Tectónicas, y ni en esta ocasión, ni en el caso de Haití, se ha verificado elasticidad alguna. Por tanto

ARTIFICIAL.UN ASESINANATO EN MASA, UN GENOCIDIO, DEL QUE TIENE QUE RENDIR CUENTAS TODOS SUS RESPONSABILIDADES

ES HORA DE ACTUAR Y DE MOVILIZARSE SIN VIOLENCIA,INFORMANDO DE LO QUE STA PASANDO

Arituclos del Blog HORDASHISPANICAS:

la verdad sobre las vacunas

Image and video hosting by TinyPic

GRIPE 1H1N.IMPLANTACION MASIVA DEL MICROCHIP



(Nosotros ya lo dijimos, se confirman las peores sospechas).
No permitas que te marquen como al ganado:

Científicos de la Universidad de Colorado han creado un chip capaz de identificar una mutaciónd el virus de la gripe aviar en sólo 11 horas. Ha sido probado con cepas específicas de otros virus de la gripe y ha funcionado en más del 90% de los casos. Los actuales métodos de diagnóstico tardan cuatro días en identificar las características genéticas de los virus, por lo que el chip, bautizado como Flu Chip o Chip de la Gripe, puede convertirse en una poderosa herramienta para prevenir y evitar futuras epidemias y pandemias. Por Yaiza Martínez de Tendencias Científicas.


la tecnologia lleva desarrolada desde hace años, y probada con exito en animales, el paso anterior para controlar a los humanos.


Epidemias y pandemias (como la que advierte la ONU sobre la gripe aviar) podrían ser detectadas en cuestión de horas en organismos humanos infectados gracias a un chip desarrollado por la universidad estadounidense de Colorado, en Boulder. Este chip es capaz de reconocer las características genéticas de cepas específicas de diversos tipos de gripe. Ya ha sido probado, con un elevado porcentaje de aciertos (más del 90%), para detectar tres virus de la gripe.



nos convertiriamos en un simple codigo, sin privacidad.


Según explica la citada universidad en un gripe española, por lo que la aparición de este chip puede cambiar la naturaleza de esta amenaza.


Image and video hosting by TinyPic
En la cartas de Steve Jackson(1995)ya se hablaba de ello.

Los escenarios plausibles de la nueva pandemia son devastadores: se calcula que entre el 20% y el 50% de la población mundial estaría afectada y que morirían entre el 10% y el 50% de los enfermos.


Fuente de la noticia:http://www.laflecha.net/canales/ciencia/noticias/200511132



Bolitin 19. Armas para defender la salud:

http://www.amcmh.org/PagAMC/downloads/gripecerdo3.htm

Esta es la noticias, sobran comentarios, todo queda dicho, aunque la noticia sea del 2005, habla claramente de las oscuras y siniestras intenciones de los gobernantes mundiales, y como llevan desde hace años con una sola idea, un gobierno mundial y posteriormente su implantación masiva de un micro-CHIP a toda la población, campañas agresivas sobre la desaparición de niños, supuestas facilidades económicas y descuentos para quienes los usen, darán todo tipo de facilidades pero tienes que revelarte y decir alto y claro NO AL MICRO -CHIP en humanos, seria como tener un ganado controlado con su marca, la marca de un mundo mas tiranos, mas controlado y con menos Libertad, un NWO el de los illuminatis

Image and video hosting by TinyPic



Obama satanico-ILLUMINATI???

Obama satanico-ILLUMINATI???
No es un truncaje, y no solo esta el

Bush satanico.ILLUMINATI???

Bush satanico.ILLUMINATI???
En realidad aparte de ser un culto a satan es un simbolo muy usado por una sociedad secreta.Los illuminati.Demasiadas evidencias para ser una casulidad no crees?

SIMBOLOGIA ILLUMINATI

Image and video hosting by TinyPic

Para entender lo que esta pasando es muy importante que sepas leer la simbología, para ellos, algo mas que sagrado, una deuda, una devoción enfermiza, que les delata y nos tendría que hacer recapacitar sobre a quienes dejamos que nos gobiernen.Puedes informarte mejor aqui:

Politicos, empresarios, famosos usnado la simbologia illuminati

Enlace video

Funeral Illuminati.Lady Bird Jhonson

SIMBOLOGIA ILLUMINATI



Quien era Lady Bird Johnson

Para entender como actuan los illuminati

Politicos y famoso declarandose publicamentes seguidores de ls illumianti.pruebas graficas


No cabe duda despues de ver este video, no podemos mas que reaccionar y ante la evidencia y contundencia de los hechos, anilazr la perspectiva geo-politica que hasta hora teniamos, la contundencia de las imagenes habla por si sola, vemos a un grupo importante de politicos y empresarios asistentes al funeral, esto no tendira mayor importancia si no fuera por lo esperpentico del acto en si, curas y miembros de la iglesia realizando un gesto mas que sospechoso, una adoracion y una esaltacion preocupantes.

Image and video hosting by TinyPic


Recuerda que esta gente tiene cargos politicos y esta elegida democraticamente, seguramente no sabais este pequeño secreto que teneian y su adoracion al maligno tampoco es un dato que nos recuerden en sus campañas de captacion de votos


DESPIERTA!!!!QUIEREN CAMBIAR EL MUNDO Y YA ESTASVIENDO QUIEN ES SU DIOS!!!!



Informate sobre lo que esta pasando y reacciona, se trata de tu libertad lo mas sagrado e importante que tenemos, informate saca tus propias conclusiones puede que este equivocado, pero cuestiona la autoridad, contrasta la informacion y busca la



VERDAD:

Simbologia illumianti ralacion directa con corrientes satanicas y su simbologia

Quienes son los siervos de satan?

Ritual Stanico de Los Bohemian Grove:
Advertencia:Este video contiene imagenes que podrian herir su sensibilidad, escenas realmente duras y macabras.


Este extraordinario documento fue filmado por el periodista e investigador Alex Jones, lo mas aterrador de todo esto es la representación y el fanatismo que presentan sus asistentes, recordando ritos que se remontan a mas de 3000 años de antigüedad, esto es un documento grafico en toda regla, una prueba mas de lo que realmente esta pasando, la realidad siempre supera a la facción, pero lo peor de todo no seria solo esto:

Si revisamos y nos documentamos sobre los Bohemian Grove, simplemente pueden documentarse en este enlace

http://en.wikipedia.org/wiki/Bohemian_Grove y

http://www.infowars.com/bg1.html

Algunos miembros de la BG:

Image and video hosting by TinyPic

Jimmy Carter
,George H.W. Bush,George W. Bush (hijo), Henry Kissinger, George Schultz

Entre otros....podemos hablar de miembros de importantes empresas, multinacionales, políticos como hemos visto de diferentes ideologías(controlan todas para asegurarse el exito), banqueros, artistas...etc...etc

No olvidemos que los Bohemian, es una rama dependiente de los ILLUMIANTI, la relación entre lo perverso y lo maléfico, así como, la adoración y culto que tienen estos fanáticos satanistas esta mas que demostrada.

Despues de ver este video, ya nunca diras YES WE CAN!!!

Confesiones de un Ganster Economico (3) John Perkins

Parte de la historia censurada,Esta parte a que nunca te la enseñaron en la escuela?

Declaracion de intenciones.Libertad y RNWO.15 de octubre de 1940,)

un comico muy serio

Listas de reproduccion.

A dia de hoy, Internet es el unico espacio realmente libre que nos queda, sin intervención de las grandes multinacionales y banqueros.Proyecto HAARP, operation black jack, annunaki, nibiru, skull and bones, bohemian grobe, sabias que estas sociedades tienen su punto de conexion con los Illuminati, estos controlaracion todas las demas, creando un entrazado muy complejo de sociedades y organizaciones, así, pueden controlar todos las partes de nuestra sociedad, hasta el Vaticano cayo en su dominio,VER CRUZ TORCIDA , ha sido lo que han estado esperando durante siglos, derrocar a la iglesia y su concepto del bien y del mal, imponiendo su NWO, nuevo orden mundial, un solo mundo bajo sus reglas y creencias satánicas, considerando al ser humano como un siervo, una raza inferior que esta aquí para servirles, os acordáis de la edad media?efectivamente nunca fueron mas felices teniendonos como autenticos esclavos a su servicio con derechos divinos y con la unica esperanza de sobrevivir, pero la lucha, la revolución y el despertar de nuestros antepasados hicieron posibles alguna conquistas sociales, que hoy perdemos poco a poco,no podemos permitir que suceda.


Image and video hosting by TinyPic

hordashispanicas


RNWO

Buscar este blog

Evolucion del virus de la libertad.RNWO Juntos venceremos!!!

MENSAJE AL MUNDO ENTERO from hordashispanicas on Vimeo.